CF
MXCT icon

Corebridge Financial’s MaxCyte MXCT Stock Holding History

Corebridge Financial’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-51,842
Closed -$142K – 1746
2025
Q1 		$142K Sell
51,842
-175
-0.3% -$690 ﹤0.01% 2261
2024
Q4 		$216K Sell
52,017
-3,927
-7% -$14.8K ﹤0.01% 2127
2024
Q3 		$218K Sell
55,944
-344
-0.6% -$1.45K ﹤0.01% 2184
2024
Q2 		$221K Buy
+56,288
New +$242K ﹤0.01% 2136

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Corebridge Financial's MXCT Position: Q2 2025 in Review

Corebridge Financial sold out of MaxCyte (MXCT) in Q2 2025, closing a stake of 51,842 shares — an estimated $142K sold.

Corebridge Financial first reported a position in MXCT in Q2 2024 and held it in 4 quarters. The position peaked at $221K in Q2 2024. 120 funds tracked by Wall St. Rank hold MXCT as of Q2 2025.

  • Corebridge Financial reported no remaining MaxCyte position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 51,842 MaxCyte shares in Q2 2025, an estimated $142K.
  • Corebridge Financial first reported a position in MaxCyte in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's MaxCyte position peaked at $221K in Q2 2024.
  • 120 funds tracked by Wall St. Rank held MaxCyte as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.